These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9132014)

  • 1. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.
    Brauns T; Prinz H; Kimball SD; Haugland RP; Striessnig J; Glossmann H
    Biochemistry; 1997 Mar; 36(12):3625-31. PubMed ID: 9132014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer.
    Berger W; Prinz H; Striessnig J; Kang HC; Haugland R; Glossmann H
    Biochemistry; 1994 Oct; 33(39):11875-83. PubMed ID: 7918406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: evidence for a functional, extracellular heparin-binding site.
    Knaus HG; Moshammer T; Friedrich K; Kang HC; Haugland RP; Glossman H
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3586-90. PubMed ID: 1314393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites.
    Knaus HG; Moshammer T; Kang HC; Haugland RP; Glossmann H
    J Biol Chem; 1992 Feb; 267(4):2179-89. PubMed ID: 1310311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue.
    Brauns T; Cai ZW; Kimball SD; Kang KC; Haugland RP; Berger W; Berjukov S; Hering S; Glossmann H; Striessnig J
    Biochemistry; 1995 Mar; 34(10):3461-9. PubMed ID: 7880840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
    Ikeda S; Oka J; Nagao T
    Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H; Wei X; Birnbaumer L
    Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels.
    Kraus RL; Hering S; Grabner M; Ostler D; Striessnig J
    J Biol Chem; 1998 Oct; 273(42):27205-12. PubMed ID: 9765241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
    Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
    J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
    Minarovic I; Mészáros LG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation.
    Berjukow S; Marksteiner R; Gapp F; Sinnegger MJ; Hering S
    J Biol Chem; 2000 Jul; 275(29):22114-20. PubMed ID: 10766758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
    Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.